Search

LTS Therapy Systems Importer Registration Application for Schedule I Controlled Substance

DEA published notice that LTS Therapy Systems, LLC (West Saint Paul, Minnesota) applied on March 6, 2026 to be registered as an importer of Dimethyltryptamine (Drug code 7435, Schedule I). The company plans to import the controlled substance as bulk API for internal research, development, and analytical purposes only. Registered bulk manufacturers and applicants may submit electronic comments or written hearing requests on or before May 18, 2026.